Product
Triluma
1 clinical trial
1 indication
Indication
MelasmaClinical trial
Efficiency And Safety Of Association Arbutin, Triamcinolone And Tretinoin In The Treatment Of Facial Melasma, Taking As Reference The Product Triluma ® (Hidroquinone, Fluoncinolone And Tretinoin).Status: , Estimated PCD: 2008-07-01